IRIS
CHIMENTI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.639
EU - Europa 4.330
AS - Asia 2.371
AF - Africa 65
SA - Sud America 50
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 22
Totale 51.516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 44.566
CN - Cina 922
SG - Singapore 820
UA - Ucraina 772
DE - Germania 725
IT - Italia 518
IE - Irlanda 480
SE - Svezia 401
FR - Francia 341
GB - Regno Unito 303
KR - Corea 174
FI - Finlandia 171
RU - Federazione Russa 156
PL - Polonia 150
IN - India 80
CA - Canada 61
BE - Belgio 46
NL - Olanda 45
PK - Pakistan 43
ES - Italia 40
JP - Giappone 37
AU - Australia 35
HK - Hong Kong 35
TR - Turchia 34
CH - Svizzera 33
EG - Egitto 33
VN - Vietnam 31
ID - Indonesia 30
BR - Brasile 27
IR - Iran 25
RO - Romania 25
KG - Kirghizistan 21
UZ - Uzbekistan 21
TW - Taiwan 20
EU - Europa 19
HU - Ungheria 17
PH - Filippine 15
SK - Slovacchia (Repubblica Slovacca) 15
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 14
GR - Grecia 14
IL - Israele 14
PT - Portogallo 13
EE - Estonia 10
NG - Nigeria 10
MX - Messico 9
ZA - Sudafrica 9
IQ - Iraq 8
AT - Austria 7
MY - Malesia 7
PE - Perù 7
CL - Cile 6
DK - Danimarca 6
HR - Croazia 6
TH - Thailandia 6
NO - Norvegia 5
RS - Serbia 5
AR - Argentina 4
BJ - Benin 4
LT - Lituania 4
LV - Lettonia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
CO - Colombia 3
EC - Ecuador 3
KW - Kuwait 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
LB - Libano 2
MD - Moldavia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
GP - Guadalupe 1
KH - Cambogia 1
LK - Sri Lanka 1
MG - Madagascar 1
NA - Namibia 1
NP - Nepal 1
OM - Oman 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 51.516
Salva come PNG Salva come JPEG
Città #
Woodbridge 13.836
Wilmington 10.937
Houston 9.548
Fairfield 1.612
Ann Arbor 1.279
Chandler 1.067
Ashburn 817
Singapore 694
Jacksonville 684
Seattle 673
Cambridge 569
Dublin 477
Medford 387
Dearborn 291
Beijing 288
Zhengzhou 265
New York 206
Lawrence 183
Santa Clara 181
Kraków 137
Rome 118
San Diego 98
Mülheim 87
Menlo Park 86
Shanghai 81
Boardman 72
Moscow 66
Redwood City 62
San Mateo 39
Hefei 37
Milan 37
Nanjing 35
London 32
Norwalk 32
Brussels 29
University Park 28
Jönköping 27
Guangzhou 25
Munich 25
Falls Church 24
Toronto 24
Verona 24
Hangzhou 21
Kunming 20
Mountain View 20
Palo Alto 20
Nanchang 19
Dong Ket 18
Auburn Hills 17
Madrid 17
Duncan 14
Tokyo 14
Helsinki 13
Los Angeles 13
Redmond 13
Stockholm 13
Detroit 12
Dubai 12
Fuzhou 12
Jakarta 12
Jinan 11
Phoenix 11
Budapest 10
Central 10
Lahore 10
Saint Petersburg 10
Salcedo 10
Cairo 9
Hounslow 9
Ottawa 9
Pune 9
São Paulo 9
Bucharest 8
Clearwater 8
Hanoi 8
Lagos 8
Melbourne 8
Nuremberg 8
Nürnberg 8
Paris 8
Taipei 8
Tallinn 8
Wuhan 8
Augusta 7
Lima 7
Seoul 7
Utrecht 7
Washington 7
Berlin 6
Chengdu 6
Chicago 6
Groningen 6
Indiana 6
Islamabad 6
Leawood 6
Napoli 6
New Delhi 6
Amsterdam 5
Bankeryd 5
Bari 5
Totale 45.808
Salva come PNG Salva come JPEG
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.400
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.177
Atopic dermatitis and dental manifestations 482
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 476
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 463
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 460
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 441
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 434
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 433
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes 432
Clinical aspects of the oral cavity in patients with psoriasis: an initial study and a proposal of a new evaluation method 432
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 429
Treatment of trachyonychia with tazarotene 428
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 421
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 421
Psoriasis, kaposi's sarcoma and hodgkin's disease in a patient with down's syndrome [2] 420
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 420
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 417
Tazarotene as alternative topical treatment for onychomycosis 416
New topical treatments for psoriasis 414
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 413
Apremilast for the treatment of psoriasis. 410
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 409
Actinic keratosis treated with an immune response modifier: a case report of six patients 408
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 407
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 407
The significance of the development of antinuclear antibodies during infliximab treatment 404
Reply to Scalone and Cortesi: ‘‘Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs’’ 402
Lung nodule and facial erythematous plaques: a quiz 399
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 398
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 397
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 397
Topical lactoferrin can improve stable psoriatic plaque 396
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 396
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 396
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 394
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 392
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 392
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 392
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 387
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 385
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 385
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice 385
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 384
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 383
Severe acne successfully treated with etanercept 383
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 382
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 382
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 381
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 381
Stress reactivity in psoriatic patients 380
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 380
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 379
Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study 377
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 377
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21 375
Treatment of lentigo maligna with tazarotene 0.1% gel 374
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus 372
Phrynoderma: a cutaneous sign of an inadequate diet 370
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 369
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 367
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 366
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 365
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 362
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 361
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 361
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 359
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 359
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome 355
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 355
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 353
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 351
Zosteriform metastasis of occult bronchogenic carcinoma 351
Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy 350
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 348
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 348
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 348
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 347
Metastatic Crohn's disease of the forehead 347
Tofacitinib for the treatment of psoriasis 347
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 346
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 340
Erysipeloid cutaneous metastasis from bladder carcinoma 339
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 339
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 338
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 337
Pyoderma vegetans and ulcerative colitis 334
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 332
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 332
HIV-associated primary cutaneous anaplastic large cell lymphoma: A clinicopathological subset with more aggressive behavior? Case report and review of the literature 332
Green sweating spots on hands and feet: unusual expression of hyperbilirubinemia 331
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 331
Ichthyosiform mycosis fungoides: A neoplastic acquired ichthyosis [5] 330
Immunologic biomarkers for clinical and therapeutic management of psoriasis 330
Zosteriform metastasis of occult bronchogenic carcinoma 329
Does metabolic syndrome influence psoriasis? 327
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 327
Dermatomyositis associated with ovarian transitional cell carcinoma 326
Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis 326
Insight into genetics of atopic dermatitis: future approaches and directions 325
Totale 39.747
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.538 0 0 876 1.213 1.010 1.364 1.157 1.198 1.073 1.105 674 868
2020/20217.104 777 802 745 867 634 674 794 695 313 240 409 154
2021/20222.158 88 275 151 139 59 177 104 115 146 186 142 576
2022/20232.793 260 230 142 409 236 586 183 156 290 27 172 102
2023/20241.156 120 52 81 50 105 290 81 106 23 38 25 185
2024/20251.420 177 811 432 0 0 0 0 0 0 0 0 0
Totale 52.311